The story of Viagra presents a interesting case for investors in the pharmaceutical sector. While initially a blockbuster success, producing billions, the exclusivity lapse and the subsequent entry of off-brand https://pharma930633.blue-blogs.com/50010810/the-little-copyright-and-pharma-a-speculative-investment